CoreWeave Stock Rebounds on Buy-the-Dip Shift

CoreWeave stock drew renewed buying after Q3 revenue strength and a $55.6B backlog, a buy-the-dip setup despite the collapsed merger and financing risk.

November 13, 2025·2 min read
View all news articles
Flat-vector server rack expanding under load to symbolize CoreWeave stock rebound and buy-the-dip interest.

KEY TAKEAWAYS

  • Q3 revenue rose 134.0% y/y and backlog jumped 271.0% to $55.6B, signaling outsized GPU demand.
  • Planned $9.0B merger collapsed, leaving limited balance-sheet flexibility and funding dependence.
  • Investors viewed the pullback as a buy-the-dip opportunity amid large backlog and deals.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

CoreWeave, Inc. (NASDAQ: CRWV) shares narrowed a recent selloff and attracted renewed buying on Nov. 13, 2025, after the company reported Q3 results showing rapid revenue growth and a sharply increased backlog, despite a collapsed merger and trimmed guidance.

Revenue Growth and Strategic Partnerships

CoreWeave’s Q3 2025 revenue rose 134.0% year-over-year, while its revenue backlog surged 271.0% to $55.6 billion, reflecting strong demand for GPU capacity from cloud and enterprise customers. This surge in bookings has prompted investors to reassess the company’s near-term prospects.

During the quarter, CoreWeave announced a $1.2 billion partnership with Vast Data and maintained capacity agreements with hyperscalers including Meta. These deals strengthen the company’s enterprise pipeline and support its effort to commercialize high-performance infrastructure as GPU-as-a-Service, a model offering graphics processing units on demand.

Merger Termination and Financial Risks

A planned $9.0 billion merger with Core Scientific was officially terminated in Q4 2025. The deal’s collapse has limited CoreWeave’s balance-sheet flexibility as it continues aggressive capacity expansion. Management slightly lowered full-year 2025 guidance, citing data-center supply-chain delays.

CoreWeave remains unprofitable and is expected to generate negative free cash flow through 2027, increasing execution and liquidity risks amid rapid growth and greater reliance on external financing. The stock retraced about 45.0% from its October 2025 highs and had a market capitalization of $42.6 billion as of Nov. 13, with a price-to-earnings ratio of -47.0.

Investor sentiment on major social platforms has shifted from bearish to neutral-to-bullish. Some market participants view the pullback as a buying opportunity, citing the large backlog and recent enterprise deals as evidence of CoreWeave’s long-term position in the GPU-as-a-Service market, despite near-term profitability and financing challenges.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

U.S.-Switzerland Trade Deal Lowers Tariffs

U.S.-Switzerland trade deal eases pressure on Swiss watch and pharmaceutical exporters and reduces a near-term sales and pricing headwind for traders.

Ron Baron Tesla Sees $2,500 Target, Holds Stakes

Ron Baron Tesla reaffirmed a lifetime hold and backed Musk's pay package, spotlighting governance and focusing investors on his $2,500 Tesla price target.

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.